Subscribe To
Nfl alumni health and paradigm anticipate touchdown for unmet osteoarthritis pain
NFL Alumni support ex-NFL players with medical symposium during NFL Draft Mount Laurel, NJ, June 27, 2023 (GLOBE NEWSWIRE) — In tandem with the NFL ...
June 27, 2023, 5:03 pm
Hip replacement implants market is likely to reach usd 7.0 bn by 2031 growing with cagr of 4.0%: tmr study
Significant rise in adoption of total hip arthroplasty (THA) procedures for end-stage degenerative hip osteoar...
May 11, 2023, 2:30 pm
Cult food science announces mou with jellatech to create collagen-enhanced pet foods
CULT Food Science Corp (CSE:CULT, OTCQB:CULTF) has announced a partnership with JellaTech, a company producing collagen through cellular agriculture,...
April 11, 2023, 8:03 am
Wellbeing digital sciences says kgk science subsidiary announces positive results from study on gj 191 supplement for osteoarthritis
Wellbeing Digital Sciences (NEO:MEDI.AQN, OTCQB:KONEF) Inc announced that a clinical study conducted by its wholly-owned subsidiary, KGK Science Inc, ...
June 16, 2022, 8:08 am
Ampio pharma shares fall as fda rejects proposed change in knee osteoarthritis trial
Ampio Pharmaceuticals Inc (NYSE: AMPE) received written responses from the FDA pursuant to a Type C meeting request regarding the AP-013 Phase 3 tria...
April 21, 2022, 6:29 am
Enveric biosciences advancing clinical plans as it announces two new molecules to treat osteoarthritis and other pain conditions
Enveric Biosciences (NASDAQ:ENVB) said that two new molecules, EV104a and EV104b, have been created to treat ...
February 8, 2022, 8:55 am
Enveric biosciences advancing clinical plans as it announces two new molecules to treat osteoarthritis and other pain conditions
Enveric Biosciences (NASDAQ:ENVB) said that two new molecules, EV104a and EV104b, have been created to treat ...
February 8, 2022, 8:55 am
Enveric biosciences advancing clinical plans as it announces two new molecules to treat osteoarthritis and other pain conditions
Enveric Biosciences (NASDAQ:ENVB) said that two new molecules, EV104a and EV104b, have been created to treat ...
February 8, 2022, 8:55 am
Enveric biosciences files provisional patent for cbd+celecoxib conjugate for osteoarthritis
Psychedelics-based neuroscience company Enveric Biosciences (NASDAQ: ENVB) announced the development of EV104a and EV104b, new molecular conjugates ...
February 8, 2022, 8:30 am
Enveric biosciences files provisional patent for cbd+celecoxib conjugate for osteoarthritis
Psychedelics-based neuroscience company Enveric Biosciences (NASDAQ: ENVB) announced the development of EV104a and EV104b, new molecular conjugates ...
February 8, 2022, 8:30 am
Enveric biosciences files provisional patent for cbd+celecoxib conjugate for osteoarthritis
Psychedelics-based neuroscience company Enveric Biosciences (NASDAQ: ENVB) announced the development of EV104a and EV104b, new molecular conjugates ...
February 8, 2022, 8:30 am